TD Private Client Wealth LLC decreased its holdings in shares of Avantor, Inc. (NYSE:AVTR – Free Report) by 63.8% in the 4th quarter, Holdings Channel reports. The institutional investor owned 8,084 shares of the company’s stock after selling 14,266 shares during the period. TD Private Client Wealth LLC’s holdings in Avantor were worth $170,000 at the end of the most recent quarter.
A number of other institutional investors and hedge funds have also modified their holdings of the business. MassMutual Private Wealth & Trust FSB grew its holdings in Avantor by 99.5% during the 4th quarter. MassMutual Private Wealth & Trust FSB now owns 1,253 shares of the company’s stock worth $26,000 after acquiring an additional 625 shares during the period. Smartleaf Asset Management LLC grew its stake in shares of Avantor by 106.3% during the fourth quarter. Smartleaf Asset Management LLC now owns 1,611 shares of the company’s stock worth $34,000 after purchasing an additional 830 shares during the period. Global Retirement Partners LLC increased its holdings in Avantor by 76.7% in the fourth quarter. Global Retirement Partners LLC now owns 2,459 shares of the company’s stock valued at $52,000 after purchasing an additional 1,067 shares during the last quarter. UMB Bank n.a. lifted its stake in Avantor by 56.3% in the fourth quarter. UMB Bank n.a. now owns 2,981 shares of the company’s stock valued at $63,000 after buying an additional 1,074 shares during the period. Finally, AlphaQuest LLC bought a new stake in shares of Avantor in the 4th quarter valued at about $65,000. 95.08% of the stock is owned by institutional investors.
Insider Transactions at Avantor
In other Avantor news, CAO Steven W. Eck sold 4,907 shares of the business’s stock in a transaction dated Wednesday, February 26th. The shares were sold at an average price of $17.53, for a total transaction of $86,019.71. Following the sale, the chief accounting officer now directly owns 40,604 shares of the company’s stock, valued at $711,788.12. The trade was a 10.78 % decrease in their position. The sale was disclosed in a filing with the SEC, which is available through this link. Also, EVP James Bramwell sold 3,758 shares of the firm’s stock in a transaction dated Wednesday, February 26th. The shares were sold at an average price of $17.53, for a total value of $65,877.74. Following the completion of the transaction, the executive vice president now owns 87,379 shares of the company’s stock, valued at $1,531,753.87. The trade was a 4.12 % decrease in their position. The disclosure for this sale can be found here. Company insiders own 1.50% of the company’s stock.
Wall Street Analysts Forecast Growth
Check Out Our Latest Analysis on Avantor
Avantor Price Performance
AVTR stock opened at $16.33 on Wednesday. The stock has a 50-day moving average price of $18.76 and a two-hundred day moving average price of $21.57. Avantor, Inc. has a 1 year low of $15.37 and a 1 year high of $28.00. The stock has a market cap of $11.12 billion, a PE ratio of 15.70, a price-to-earnings-growth ratio of 1.55 and a beta of 1.30. The company has a current ratio of 1.07, a quick ratio of 0.70 and a debt-to-equity ratio of 0.54.
Avantor (NYSE:AVTR – Get Free Report) last posted its quarterly earnings data on Wednesday, February 12th. The company reported $0.27 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $0.26 by $0.01. Avantor had a return on equity of 12.17% and a net margin of 10.49%. During the same quarter in the prior year, the firm earned $0.22 earnings per share. Equities analysts forecast that Avantor, Inc. will post 1.06 EPS for the current fiscal year.
About Avantor
Avantor, Inc engages in the provision of mission-critical products and services to customers in the biopharma, healthcare, education and government, advanced technologies, and applied materials industries in the Americas, Europe, Asia, the Middle East, and Africa. The company offers materials and consumables, such as purity chemicals and reagents, lab products and supplies, formulated silicone materials, customized excipients, customized single-use assemblies, process chromatography resins and columns, analytical sample prep kits, education and microbiology products, clinical trial kits, peristaltic pumps, and fluid handling tips.
See Also
- Five stocks we like better than Avantor
- 3 Stocks to Consider Buying in October
- Innovation Incubators: Survey of Entrepreneurs Reveals The Cities Most Supportive of Startups
- How to Calculate Retirement Income: MarketBeat’s Calculator
- NVIDIA Insiders Sell: This Is What It Means for the Market
- How to Calculate Stock Profit
- Space Stocks Bottoming: Which Are Positioned Best for a Bounce?
Want to see what other hedge funds are holding AVTR? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Avantor, Inc. (NYSE:AVTR – Free Report).
Receive News & Ratings for Avantor Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Avantor and related companies with MarketBeat.com's FREE daily email newsletter.